Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat

Circulation

Volumn 96, Issue 11, 1997, Pages 4002-4010

  Brooks, Wesley W ^a,b,c   Bing, Oscar H L ^a,b   Robinson, Kathleen G ^a,b   Slawsky, Mara T ^a,b   Chaletsky, David M ^a,b   Conrad, Chester H ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme inhibition myocardial fibrosis; Heart failure; Myocardial hypertrophy

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART PAPILLARY MUSCLE; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRESS STRAIN RELATIONSHIP;

EID: 0030657940     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.11.4002     Document Type: Article

References (47)

1. Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension: man and rat. Circ Res. 1981;48:309-319.
2. Frohlich ED, Trippodo NC. Response to 'The rat with spontaneous genetic hypertension is a suitable model of human essential hypertension.' Circ Res. 1981;48:464. Letter.
3. Conrad CH, Brooks WW, Robinson KG, Bing OHL. Impaired myocardial function in the spontaneously hypertensive rat with heart failure. Am J Physiol. 1991;260:H136-H145.
4. Sen S, Tarazi RC, Khairallah PA, Bumpus FM. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res. 1974;35:775-781.
5. Sen S, Smeby RR, Bumpus FM. Renin in rats with spontaneous hypertension. Circ Res. 1972;31:876-880.
6. Pfeffer MA, Frohlich ED. Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats. Circ Res. 1973;32(suppl I):I-28-I-38.
7. Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol. 1979;237:H461-H468.
8. Bing OHL, Wiegner AW, Brooks WW, Fishbein MC, Pfeffer JM. Papillary muscle structure function relations in the aging spontaneously hypertensive rat. Clin Exp Hypertens. 1988;10:37-58.
9. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OHL. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation. 1995;91:161-170.
10. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci U S A. 1982;79:3310-3314.
11. Bing OHL, Brooks WW, Conrad CH, Sen S, Perreault CL, Morgan JP. Intracellular calcium transients in myocardium from spontaneously hypertensive rats during the transition from hypertrophy to failure. Circ Res. 1991;68:1390-1400.
12. Boluyt MO, O'Neill, Meredith AL, Bing OHL, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to failure. Circ Res. 1994;75:23-32.
13. Parmley WW. Angiotensin converting-enzyme inhibitors in the treatment of heart failure. In: Cohen JN, ed. Drug Treatment of Heart Failure. Secaucus, NJ: Advanced Therapeutics Communications International; 1988:227-250.
14. Bing OHL, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol. 1995;27:383-396.
15. Wiegner AW, Bing OHL. Laser scanner measurement of central segment performance in isolated cardiac muscle preparations. Am J Physiol. 1979;237:H260-H264.
16. Weber KT, Sun Y, Tyagi SC, Cleutjens JPM. Collagen network of the myocardium: functional, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol. 1994;26:279-292.
17. ColorImage 1.31. A 24-bit color extension of NIH Image, a public domain image processing package by Wayne Rasband, NIH, with color extensions by Joseph Ayers and Garth Fletcher. Bethesda, Md: National Institutes of Health; 1991.
18. Prophet Statistics. A User's Guide to Statistical Analysis on the Prophet System. Cambridge, Mass: BBN Systems and Technologies; 1988.
19. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res. 1991;69:107-115.
20. Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman S. Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats: effects of chronic angiotensin converting enzyme inhibition. Circulation. 1991;83:1028-1037.
21. Smits JFM, van Krimpen C, Schoemaker RG, Cleutjens JPM, Daemen MJAP. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol. 1992;20:772-778.
22. Mirsky I, Pfeffer JM, Pfeffer MA. Mechanical properties of normal and hypertrophied myocardium; is there a relationship between diastolic and systolic function? Cardiovasc Res. 1983;7:39-55.
23. Sen S. Regression of hypertrophy: experimental animal model. Am J Med. 1983;75(suppl 3A):87-93.
24. Linz W, Scholkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and reduces regression of cardiac hypertrophy in rats. Clin Exp Hypertens [A]. 1989;1:1325-1350.
25. Kromer EP, Reigger GA. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am J Cardiol. 1988;62:161-163.
26. Baker KM, Chernin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 1990;259:H324-H332.
27. Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, Schunkert H, Benedict CR, Lorell BH. Angiotensinconverting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation. 1994;90:1410-1422.
28. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 1993;88:2849-2861.
29. 1 and phorbol myristate acetate on cardiac fibroblasts: regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res. 1991;69:483-490.
30. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809-820.
31. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol. 1990;259:H610-H618.
32. Marban E, Koretsune Y. Cell calcium, oncogenes, and hypertrophy. Hypertension. 1990;15:652-658.
33. Fisher SA, Absher M. Norepinephrine, and ANG II stimulate secretion of TGF-β by neonatal cardiac fibroblasts in vitro. Am J Physiol. 1995;268:C910-C917.
34. van Krimpen C, Smits JFM, Cleutjens JPM, Debets JJM, Schoemaker RG, Struyker Boudier HAJ, Bosman FT, Daemen MJAP. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol. 1991;23:1245-1253.
35. Pahor M, Bernabei R, Sgadari A, Gambassi G Jr, Giudice PL, Pacifice L, Ramacci MT, Lagrasta C, Olivetti G, Carbonin P. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension. 1991;18:148-157.
36. Urata H, Healy B, Stewart RW, Bumpus M, Husain A. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res. 1990;66:883-890.
37. VanHoutte PM, Boulanger CM, Vidal M, Monbouli JV. Endothelium-derived mediators and the renin-angiotensin system. In: The Renin-Angiotensin System. Vol 1, Biochemistry, physiology. London, UK: Gower Publishing; 1993.
38. Suzuki F, Hellman T, Murakami K, Ludwig G. Expression of the genes for renin and angiotensinogen in tissues of rats. Naunyn-Schmiedebergs Arch Pharma. 1987;335:R66. Abstract.
39. Kanapuli SP, Kumar A. Molecular cloning of the human angiotensinogen cDNA and evidence for the presence of its mRNA in rat heart. Circ Res. 1987;60:786-790.
40. Ohkubu H, Nakayama K, Tanaka I, Nakanishi S. Tissue distribution of rat anglotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem. 1986;261:319-323.
41. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991;69:475-482.
42. Sun Y, Weber KT. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res. 1994;28:1623-1628.
43. Brilla CG, Maisch B, Weber KT. Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease in vivo and in vitro studies on collagen matrix regulation. Clin Invest. 1993;71:S35-S41.
44. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell, BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest. 1990;86:1913-1920.
45. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res. 1994;28:1423-1432.
46. Sun Y, Weber KT. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res. 1994;28:1623-1628.
47. Gohlke P, Linz W, Scholkens BA, Wiemer G, Martorana P, van Even P, Unger T. Effect of chronic high- and low-dose ACE inhibitor treatment on cardiac and vascular hypertrophy and vascular function in spontaneously hypertensive rats. Exp Nephrol. 1994;2:93-99.